ondansetron
information and resources from the National Cancer Institute
ondansetron
A carbazole derivative with antiemetic activity. As a selective serotonin receptor antagonist, ondansetron competitively blocks the action of serotonin at 5HT3 receptors, resulting in suppression of chemotherapy- and radiotherapy-induced nausea and vomiting.
|
|
|
|
news articles
American Pharmaceutical Partners Receives 2 Tentative FDA ... Mar 9, 2006
Trading Markets, ...that it had received two tentative approvals from the US Food and Drug Administration for its Abbreviated New Drug Applications for Ondansetron Injection, USP ...
American Pharma Partners Granted 2 Tentative FDA Approvals For ... Mar 9, 2006
Trading Markets, ...(APPX | charts | news | Powerrating) on Thursday morning said it has received two tentative approvals from the FDA for its ANDAs for Ondansetron Injection, USP ...
NovaDel Announces That Ondansetron Oral Spray Has Met The Key ... Mar 9, 2006
Business Wire (press release), ...-- Pivotal pharmacokinetic study confirms that ondansetron 8 mg oral spray is statistically bioequivalent to 8 mg ondansetron (Zofran(R)) tablet, meeting the ...
-- Hana targets US commercial launch of ondansetron oral spray in Mar 9, 2006
PharmaLive.com (press release), ...(AMEX: NVD) today announced that Hana Bioscienses, NovaDel's partner in the development and commercialization of Zensana(TM) (ondansetron oral spray), has ...
American Pharmaceutical Partners Receives Two Tentative FDA ... Mar 9, 2006
PR Newswire (press release), ...received two tentative approvals from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Applications (ANDAs) for Ondansetron Injection, USP ...
Boy Dies After Swallowing Lead-Filled Charm Mar 31, 2006
MedPage Today, Doctors there diagnosed probable viral gastroenteritis and administered Zofran (ondansetron) and sent home with instructions to parents to monitor fluid intake ...
Highlights From MMWR: Outbreaks of MRSA Infection in Newborns and ... Mar 31, 2006
Medscape (subscription) ...vomiting. Upon being diagnosed with probable viral gastroenteritis, the child received treatment with ondansetron and was released. ...
Hana Biosciences Successfully Completes Pivotal Trials of Zensana ... Mar 9, 2006
Business Wire (press release), ...-- Positive pivotal studies confirm Zensana(TM) (ondansetron oral spray) 8 mg dose is statistically bioequivalent to the current commercially available 8 mg ...
Hikal gets European nod for anti-emetic product Mar 17, 2006
India Infoline.com, Certificate of Suitability (CoS) from the European Directorate for the Quality of Medicines (EDQM) for one of its products, Ondansetron Hydrochloride Dihydrate ...
Hana Paying Up To $42M For Inex’s Cancer Drugs Mar 17, 2006
BioWorld Online (subscription), Earlier this month, Hana completed all clinical trials of Zensana (ondansetron oral spray) required for FDA registration to treat chemotherapy-induced nausea ...
Hana Biosciences Reports 2005 Results from Operations Mar 16, 2006
Genetic Engineering News, Zensana(TM) (ondansetron oral spray), for the prevention of chemotherapy and radiation-induced, and post-operative nausea and vomiting, completed a pilot ...
NovaDel Reports Second Fiscal Quarter Results Mar 16, 2006
Genetic Engineering News, Announcement of positive study results of the pivotal clinical trials for Zensana(TM) Ondansetron Oral Spray, by our partner, Hana Biosciences. ...
American Pharmaceutical drug gets FDA approval Mar 9, 2006
Crain's Chicago Business, The drug, known generically as ondansetron, is used to prevent nausea and vomiting suffered by cancer patients undergoing certain chemotherapy. ...
SCOLR Pharma Reports Results for 2005 Mar 23, 2006
Business Wire (press release), ...commercialization.". -- Completed pilot bioavailability trial for our 24 hour extended release CDT-based ondansetron formulations - December '05. ...
Select AIDS, cancer drugs to become cheaper Mar 2, 2006
Sify, ...to see a downward price revision are cisplatin, cytosine arabinoside, danazol, daunorubicin HCL, etoposide, flutamide, ondansetron, pacitaxel, tamoxifen citrate ...
American Pharma Gets Tentative Zofran OK Mar 9, 2006
MSN Money The approvals cover single-dose and multiple-dose vials of injectable ondansetron, the active ingredient in Zofran, for the treatment of nausea and vomiting ...
(PRN) - New Drug Formulations Most Popular Counter-Generic ... Mar 9, 2006
Bolsamania.com, Sales ... [+. PRN) - American Pharmaceutical Partners Receives Two Tentative FDA Approvals for Ondansetron Injection, USP ... [+. ...
Hikal's anti-nausea drug certified in Europe Mar 16, 2006
Sify, The European Directorate for Quality of Medicines gave the certificate for Hikal's ondansetron hydrochloride dihydrate, Jai Hiremath, the company's Vice ...
NovaDel Pharma Q2 Net Loss Widens On Higher Expenses; Reveals ... Mar 16, 2006
Trading Markets, In the second quarter, NovaDel's partner Hana Biosciences announced positive study results of clinical trials for Zensana Ondansetron Oral Spray, demonstrating ...
[ Local Focus ] Mar 10, 2006
International News Service, ...on Thursday announced it has received two tentative approvals from the US Food and Drug Administration for Ondansetron Injection, the company's generic version ...
Hana Biosciences Initiates Pivotal Trials of Zensana(TM), First ... Dec 12, 2005
Genetic Engineering News, ...is initiating today a series of pivotal pharmacokinetic trials, including comparison of Zensana(TM) to the commercially available ondansetron tablet (Zofran(R ...
Pliva says ondansetron hydrochloride gets FDA approval Nov 21, 2005
Forbes LONDON (AFX) - PLIVA said ondansetron hydrochloride (HC1) orally disintegrating tablets (ODT) for treating chemotherapy-associated nausea and vomiting, which ...
PLIVA Announces Approval for Ondansetron Hydrochloride ODT Nov 21, 2005
Chemie.de (press release), 11/22/2005 - PLIVA dd announced that its partner on ondansetron hydrochloride (HCl) orally disintegrating tablets (ODT) in 4 mg and 8 mg strengths, Kali ...
NovaDel Reports First Fiscal Quarter Results Dec 15, 2005
Genetic Engineering News, ...zolpidem (Ambien(R)). -- IND filed for ondansetron (Zensana(TM)) by the Company's partner, Hana Biosciences. -- Completed build-out ...
Hana Biosciences Announces Changes to Strengthen Management Team Dec 16, 2005
Business Wire (press release), ...medical officer and will assume the overall leadership of the company's development pipeline including Talotrexin (PT-523), Zensana (ondansetron oral spray ...
Hana Biosciences Reports Third Quarter Results Dec 14, 2005
Genetic Engineering News, These include: -- Zensana(TM), the first ondansetron oral spray in chemotherapy-induced nausea and vomiting, demonstrated a bioequivalence profile comparable ...
Par Pharmaceutical Receives Approval and Marketing Exclusivity for ... Nov 21, 2005
Yahoo! News (press release) ...has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for ondansetron hydrochloride (HCl ...
First-Time Generic Approvals: Metaglip, Zofran ODT, Floxin Otic Nov 22, 2005
Medscape (subscription) 2.5-mg/500-mg, and 5-mg/500-mg tablets for first- and second-line use to improve glycemic control in patients with type 2 diabetes mellitus; ondansetron 4- and ...
GlaxoSmithKline: Zofran sales set for off-Par performance Nov 22, 2005
Pharmaceutical Business Review The approval means Par subsidiary Kali Laboratories will be free to launch a generic version of GlaxoSmithKline's (GSK) Zofran (ondansetron HCI) , a 5 ...
Govt medicine spending slammed as 'pathetic' Dec 5, 2005
Stuff.co.nz, ...for patients who had heart failure (candesartan), breast cancer (letrozole), nausea from cancer treatments (hyoscine, ondansetron, tropisetron), hepatitis B ...
How to Break the Chain Dec 10, 2005
Newsweek ...aminobutyric acid). Yet another candidate is ondansetron, a serotonin blocker used to treat nausea in cancer patients. Studies suggest ...
Par Unit Gets FDA OK for Generic Zofran Nov 21, 2005
MSN Money ...drug. The approval covers 4 milligram and 8 milligram tablets of ondansetron hydrochloride, the active ingredient in Zofran. The ...
FDA approves Par's generic Zofran Nov 21, 2005
United Press International The generic drug -- an ondansetron hydrochloride tablet -- is made by Par unit Kali Laboratories. Kali is presently embroiled in patent litigation with GSK.
Holiday temptations Nov 21, 2005
News-Herald.com, ...side effects of quitting. Naltrexone, Ondansetron and Campral are examples of such medications, he said. Vacovsky adds that the ...
NJ business briefs Nov 22, 2005
NorthJersey.com, ...drug. The drug, ondansetron, is used to prevent nausea and vomiting caused by chemotherapy and radiation therapy. GlaxoSmithKline ...
FDA rescinds generic Zofran approval Nov 29, 2005
United Press International Zofran patent. FDA cleared for market Kali's ondansetron orally-disintegrating tablets in 4 mg and 8 mg strengths Nov. 18. FDA said ...
|
|
